IMUX EPS Estimates
Immunic, Inc.
$7.56
-$0.07(-0.92%)
30
Overall
60
Value
18
Tech
13
Quality
Market Cap
$104.11M
Volume
588.75K
52W Range
$5.06 - $17.43
Target Price
$43.09
IMUX EPS estimates: the consensus estimate for Immunic, Inc.'s current fiscal year is -$3.71 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IMUX EPS Estimates
- EPS estimate, current quarter
- $-0.82
- EPS estimate, next quarter
- $-0.80
- EPS estimate, current year
- $-3.71
- EPS estimate, next year
- $-2.74
- EPS growth, 3-year
- +74.59%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.62 |
| 2024 | $-10.00 |
| 2023 | $-21.10 |
| 2022 | $-37.80 |
| 2021 | $-39.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMUX | $7.56 | -0.9% | 588.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |